Loading...
Surmodics, Inc.
SRDX•NASDAQ
Healthcare
Medical - Devices
$36.00
$3.95(12.32%)
Surmodics, Inc. (SRDX) Financial Performance & Income Statement Overview
Review Surmodics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.91%
↓ 4.91%
Operating Income Growth
-209.61%
↓ 209.61%
Net Income Growth
-651.43%
↓ 651.43%
Operating Cash Flow Growth
-97.64%
↓ 97.64%
Operating Margin
-10.26%
↓ 10.26%
Gross Margin
72.65%
↑ 72.65%
Net Profit Margin
-16.34%
↓ 16.34%
ROE
-17.31%
↓ 17.31%
ROIC
-8.36%
↓ 8.36%
Surmodics, Inc. (SRDX) Income Statement & Financial Overview
Review Surmodics, Inc.'s (SRDX) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $29.92M | $33.23M | $30.34M | $31.96M |
Cost of Revenue | $7.42M | $8.67M | $9.32M | $7.98M |
Gross Profit | $22.50M | $24.55M | $21.02M | $23.98M |
Gross Profit Ratio | $0.75 | $0.74 | $0.69 | $0.75 |
R&D Expenses | $2.74M | $2.69M | $9.77M | $10.23M |
SG&A Expenses | $15.17M | $14.58M | $16.63M | $13.09M |
Operating Expenses | $24.98M | $25.17M | $26.39M | $23.32M |
Total Costs & Expenses | $32.40M | $33.84M | $35.71M | $31.30M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $882000.00 | $884000.00 | $879000.00 | $881000.00 |
Depreciation & Amortization | $2.08M | $2.14M | $2.13M | $2.10M |
EBITDA | $21000.00 | $1.002M | -$2.81M | $2.75M |
EBITDA Ratio | $0.001 | $0.03 | -$0.09 | $0.09 |
Operating Income | -$2.48M | -$613000.00 | -$5.37M | $659000.00 |
Operating Income Ratio | -$0.08 | -$0.02 | -$0.18 | $0.02 |
Other Income/Expenses (Net) | -$463000.00 | -$524000.00 | -$442000.00 | -$493000.00 |
Income Before Tax | -$2.94M | -$1.14M | -$5.81M | $166000.00 |
Income Before Tax Ratio | -$0.10 | -$0.03 | -$0.19 | $0.005 |
Income Tax Expense | $707000.00 | $2.31M | $1.74M | -$81000.00 |
Net Income | -$3.65M | -$3.45M | -$7.55M | $247000.00 |
Net Income Ratio | -$0.12 | -$0.10 | -$0.25 | $0.008 |
EPS | -$0.26 | -$0.24 | -$0.53 | $0.02 |
Diluted EPS | -$0.26 | -$0.24 | -$0.53 | $0.02 |
Weighted Avg Shares Outstanding | $14.23M | $14.19M | $14.17M | $14.15M |
Weighted Avg Shares Outstanding (Diluted) | $14.23M | $14.19M | $14.17M | $14.18M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan